4.5 Article

Changes in body mass in later life and incident dementia

期刊

INTERNATIONAL PSYCHOGERIATRICS
卷 25, 期 3, 页码 467-478

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S1041610212001834

关键词

Alzheimer disease; dementia; epidemiology; health aging; metabolic diseases

资金

  1. National Health and Medical Research Council of Australia (NHMRC) [279408, 379600, 403963]
  2. MBF Foundation of Australia [DS 080608]

向作者/读者索取更多资源

Background: There is ongoing debate about whether a decline in body mass represents a true risk factor for dementia, whether it is a phenotypic marker of incipient dementia, or perhaps a marker of another process that increases dementia risk. This study was designed to determine if changes in body mass index (BMI) in later life are associated with hazard of incident dementia over a follow-up period of up to eight years. Methods: Method followed was a prospective cohort study of 4,181 men aged 65-84 years, resident in Perth, Australia. The exposure of interest was change in BMI measured between 1996-1998 and 2001-2004. The outcome was incident dementia, established using the Western Australia Data Linkage System until 2009. We used Cox regression models to establish crude and adjusted hazard of dementia for change in BMI. Results: Compared with men with a stable BMI, those with a decrease in BMI >1 kg/m(2) had a higher adjusted hazard of dementia (hazard ratio (HR)= 1.89, 95% CI = 1.32-2.70). The cumulative hazard of dementia over follow-up for changes in BMI was greatest for men with a decrease in BMI >1 kg/m(2); this trend was apparent for men in all BMI categories (underweight, normal, overweight, obese). A reverse J-shaped association between BMI change and incident dementia was observed, with the lowest dementia rate being for men whose BMI remained stable. Conclusions: Men who maintained a stable body mass had the lowest incidence of dementia. Further studies are needed to clarify causality and assess feasibility of interventional studies to preserve body mass in aging men.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Patient Controlled Analgesia and its effect on postoperative outcomes in an older cohort of patients undergoing orthopaedic procedures: A retrospective observational study

Mayura Thilanka Iddagoda, Andrew Nienaber, Carina Pretorius, Leon Flicker

Summary: This study reviewed the records of 305 older patients undergoing orthopaedic surgeries and found that patients who received Patient Controlled Analgesia had worse physical function on day 3, longer hospital stays, and higher odds of needing support on discharge. Surprisingly, pain control was also poor in the Patient Controlled Analgesia group.

JOURNAL OF PERIOPERATIVE PRACTICE (2023)

Article Geriatrics & Gerontology

Effect of vitamin D supplementation on depression in older Australian adults

Sabbir T. Rahman, Mary Waterhouse, Briony Duarte Romero, Catherine Baxter, Dallas R. English, Osvaldo P. Almeida, Michael Berk, Peter R. Ebeling, Bruce K. Armstrong, Donald S. A. McLeod, Gunter Hartel, Rachel L. O'Connell, Hai Pham, James G. Scott, Jolieke C. van der Pols, Alison J. Venn, Penelope M. Webb, David C. Whiteman, Rachel E. Neale

Summary: The study investigated whether vitamin D supplementation reduces depressive symptoms and incidence of antidepressant use. The results showed that high-dose monthly supplementation with vitamin D-3 did not have overall benefit for measures of depression, but there was some evidence of benefit in subgroup analyses.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Article Psychology, Clinical

Is incident cancer in later life associated with lower incidence of dementia?

Osvaldo P. Almeida, Graeme J. Hankey, Bu B. Yeap, Jonathan Golledge, Christopher Etherton-Beer, Suzanne Robinson, Leon Flicker

Summary: Cancer is associated with a lower risk of dementia, although methodological issues raise concerns about this relationship. A long-term study of 31,080 men aged 65-85 years found that the hazard ratio of dementia associated with cancer was 1.13, but dropped to 0.85 when excluding participants who developed dementia within 2 years. The diagnosis of cancer seems to facilitate the early detection of dementia cases.

INTERNATIONAL PSYCHOGERIATRICS (2023)

Article Geriatrics & Gerontology

Vitamin D supplementation and cognition-Results from analyses of the D-Health trial

Hai Pham, Mary Waterhouse, Sabbir Rahman, Catherine Baxter, Briony Duarte Romero, Donald S. A. McLeod, Bruce K. Armstrong, Peter R. Ebeling, Dallas R. English, Gunter Hartel, Michael G. Kimlin, Rachel L. O'Connell, Jolieke C. van der Pols, Alison J. Venn, Penelope M. Webb, David C. Whiteman, Osvaldo P. Almeida, Rachel E. Neale

Summary: A randomized controlled trial found that monthly bolus doses of vitamin D supplementation for 5 years did not improve cognitive function in older adults.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2023)

Letter Medicine, General & Internal

Different estimates of the prevalence of dementia in Australia, 2021

Annette J. Dobson, Leon Flicker, Osvaldo P. Almeida, Michael Waller, Kaarin Anstey

MEDICAL JOURNAL OF AUSTRALIA (2023)

Article Clinical Neurology

Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trial

Yongjun Wang, Jiejie Li, S. Claiborne Johnston, Graeme J. Hankey, J. Donald Easton, Xia Meng, Fu-Dong Shi, Yilong Wang, Xingquan Zhao, Zixiao Li, Liping Liu, Hongqiu Gu, Yong Jiang, Anxin Wang, Yuesong Pan, Jing Jing, Siying Niu, Hao Li

Summary: The CHANCE-3 study is a randomized, double-blind, placebo-controlled multicenter trial that aims to investigate the efficacy of colchicine therapy in patients with acute minor-to-moderate ischemic stroke or transient ischemic attack. The study will randomly assign 8,238 patients with high-sensitivity CRP level of >= 2 mg/L to receive colchicine or placebo, in addition to optimal medical therapy. The primary outcome is the occurrence of any stroke within 3 months of randomization, with a goal of detecting a 25% reduction in the colchicine group.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Neuroimaging

Rebleeding following aneurysmal subarachnoid hemorrhage before 'endovascular first' treatment: a retrospective case-control study of published scoring systems

Arosha S. Dissanayake, Emalee Burrows, Kwok M. Ho, Timothy J. Phillips, Stephen Honeybul, Graeme J. Hankey

Summary: In a retrospective analysis of patients with aneurysmal subarachnoid hemorrhage (aSAH) treated with ultra-early intervention, the World Federation of Neurosurgical Societies (WFNS) grade was found to be superior to three published models for predicting re-bleeding.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2023)

Article Geriatrics & Gerontology

Balance and Strength Measures are Associated With Mortality in Older Men

Jack Paterson, Michelle Trevenen, Keith Hill, Osvaldo P. Almeida, Bu B. Yeap, Jonathan Golledge, Graeme J. Hankey, Leon Flicker

Summary: This study found that poorer balance and strength performance are associated with future all-cause and cardiovascular mortality, and balance is equal to strength as a modifiable risk factor for cause-specific mortality.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2023)

Article Multidisciplinary Sciences

Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial

Sophia G. G. Connor, Timothy J. J. Fairchild, Yvonne C. C. Learmonth, Kelly Beer, Ian Cooper, Glenn Boardman, Shaun Y. M. Teo, Behnaz Shatahmasseb, Rui Zhang, Krystyne Hiscock, Jerome D. D. Coudert, Bu B. B. Yeap, Merrilee Needham

Summary: This study aimed to assess whether a combination of testosterone supplementation and exercise training would improve muscle strength, physical function, and quality of life in men affected by IBM. The results showed that adding testosterone supplementation did not significantly improve muscle strength or physical function over a 12-week intervention period, compared to exercise alone. However, the combination treatment improved emotional well-being and relative stabilisation of disease was found during the 12-month extension study. Therefore, further research involving a longer duration and larger group of participants is warranted to confirm these findings.

PLOS ONE (2023)

Article Clinical Neurology

Secondary prevention of stroke. A telehealth-delivered physical activity and diet pilot randomized trial (ENAbLE-pilot)

Coralie English, Emily R. Ramage, John Attia, Julie Bernhardt, Billie Bonevski, Meredith Burke, Margaret Galloway, Graeme J. Hankey, Heidi Janssen, Richard Lindley, Elizabeth Lynch, Chris Oldmeadow, Catherine M. Said, Neil J. Spratt, Karly Zacharia, Lesley MacDonald-Wicks, Amanda Patterson

Summary: This study tested the feasibility and safety of a 6-month telehealth intervention to increase physical activity and improve diet quality. The results showed that the intervention was safe and feasible and may have led to significant behavior change.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Clinical Neurology

Usability and feasibility of PreventS-MD web app for stroke prevention

Valery L. Feigin, Rita Krishnamurthi, Oleg Medvedev, Alexander Merkin, Balakrishnan Nair, Michael Kravchenko, Shabnam Jalili-Moghaddam, Suzanne Barker-Collo, Yogini Ratnasabapathy, Luke Skinner, Mayowa Owolabi, Bo Norrving, Perminder S. Sachdev, Bruce Arroll, Michael Brainin, Amanda Thrift, Graeme J. Hankey

Summary: The PreventS-MD web app showed high usability, feasibility, and satisfaction among healthcare professionals (HCPs) and individuals at risk of stroke/CVD. Patients at risk of stroke/CVD also demonstrated strong confidence and motivation in following and adhering to the preventive recommendations generated by PreventS-MD.

INTERNATIONAL JOURNAL OF STROKE (2023)

Review Medicine, General & Internal

Antithrombotic treatment after stroke due to intracerebral haemorrhage

A. Cochrane, C. Chen, J. Stephen, O. M. Ronning, C. S. Anderson, G. J. Hankey, Al-Shahi R. Salman

Summary: This study aimed to determine the overall effectiveness and safety of antithrombotic drugs in reducing major adverse cardiovascular events (MACE) for stroke survivors with intracerebral hemorrhage (ICH). The results showed that long-term therapeutic dose oral anticoagulation may reduce MACE and major occlusive vascular events, while short-term prophylactic dose anticoagulation and long-term antiplatelet therapy did not show significant effects. However, the certainty of the evidence was moderate, and further large-scale randomized controlled trials are needed to address the ongoing dilemmas of antithrombotic treatment after ICH.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2023)

Article Geriatrics & Gerontology

Dispensing of antineoplastic medications and their impact on the dispensing of anti-dementia drugs for adults aged ≥60 years: A cohort study

Osvaldo P. Almeida, Christopher Etherton-Beer, Frank Sanfilippo, David B. Preen, Amy Page

Summary: The use of antineoplastic medications has been found to be associated with a decreased risk of dementia, which may contribute to the development of novel approaches for dementia prevention.

MATURITAS (2024)

Review Clinical Neurology

Pre-treatment re-bleeding following aneurysmal subarachnoid hemorrhage: A systematic review of published prediction models with risk of bias and clinical applicability assessment

Arosha S. Dissanayake, Kwok M. Ho, Timothy J. Phillips, Stephen Honeybul, Graeme J. Hankey

Summary: This study systematically reviews models that aim to provide patient-specific predictions of pre-treatment rebleeding risk in patients with aneurysmal subarachnoid hemorrhage. The reported discriminative performance of the models varied, and no model showed consistently low bias risk and clinical applicability in all domains. Only one model was formulated using a patient cohort that underwent contemporary, evidence-based aneurysm treatment practices, but this model lacked calibration or clinical utility.

JOURNAL OF CLINICAL NEUROSCIENCE (2024)

暂无数据